Preliminary data suggest a beneficial effect of sodium-glucose co-transporter-2 (SGLT-2) inhibitors.254 Although there are no data evaluating the effect on ES recurrence specifically, optimization of HF treatment is important and should follow current guidelines.255 In patients with cCAD, complete revascularization may be beneficial.256. Here, SLC5A2 is linked to hydrops fetalis.